Background {#Sec1}
==========

Legionnaires' disease (LD), a severe pneumonia caused by *Legionella*, represents 2--9% of cases of community-acquired pneumonia. There are more than 70 species and serogroups, but *Legionella pneumophila* serogroup 1 (Lp1) is responsible for more than 85% of cases of LD worldwide, while non-Lp1 infections occur more frequently in immunosuppressed patients \[[@CR1]\]. Extrapulmonary infections, including arthritis, are scarce and not systematically related to pneumonia, suggesting a multi-faceted infectious process. Herein, we report a case of *L. bozemanii* monoarthritis in an immunosuppressed woman, following a fall on wet asphalt and intra-articular corticosteroid (CS) injections.

Case presentation {#Sec2}
=================

A 56-year-old woman was hospitalized in the rheumatology department for worsening pain and swelling of the left wrist over the 3 preceding days. Her medical history included type 1 diabete and anti-synthetase syndrome diagnosed 1 year previously and which was characterized by polyarthritis, dermatomyositis and interstitial lung disease, and treated by prednisone 10 mg/day, methotrexate (MTX) 20 mg/week, and tocilizumab 560 mg/month. During the 2 previous months, she suffered from stage-II synovitis of the left wrist predominant at radiocarpal and middle carpal joints, associated with flexor and extensor digitorum communis tenosynovitis; she received 2 intra-articular injections of triamcinolone 2 months and 3 days before admission.

On admission, the patient showed left wrist synovitis with no fever. Clinical examination found a wound of the 3rd proximal interphalangeal joint, related to an accidental fall on wet asphalt 4 days before. The blood count and C-reactive protein were normal. Chest X-ray showed no worsening of the interstitial lung disease. Blood samples were collected for culture. Over the following days, while she remained afebrile, local symptoms worsened, with onset of a painful epitrochlear lymphadenopathy. On day 4, a septic arthritis was suspected and aspiration of the left wrist fluid was performed; hemorrhagic fluid with a white blood cell count of 15.7 G/L and a neutrophil count of 8.0 G/L (51%) was found. One sample was sent to the microbiology laboratory; Gram stain revealed no microorganism. An intravenous anti-staphylococcal antibiotic therapy (oxacillin 12 g/day, gentamicin 240 mg/day) was initiated. On day 6, routine wrist fluid culture remained sterile, 16S rRNA \[[@CR2]\] and *Staphylococcus* PCRs were negative, and blood cultures also remained sterile. On day 9, while the patient had improved, an inflammatory aspect of the back of the hand and severe pain persisted. The antibiotic spectrum was broadened to piperacillin-tazobactam 12 g/day and vancomycin 2 g/day on infectiologist advice. On day 14, the patient had not improved and she underwent emergency surgery that found phlegmon of the F2 and F5 sheaths, requiring drainage and arthroscopic joint lavage. Six samples were sent to the microbiology laboratory; after 14 days of culture (day 28) a single *Lysinibacillus fusiformis* colony was found in 1 sample, and rare *Cutibacterium acnes* colonies in a second sample, which were considered as contaminants. On day 29, the 16S rRNA PCRs were positive for *Legionella* spp. for 2 of the 4 sterile samples. The 23S--5S PCR performed on these samples identified *L. bozemanii*. The antibiotic regimen was modified to a 12-week course of oral levofloxacin 1 g/day and rifampin 1.2 g/day, and the symptoms quickly resolved. The immunosuppressive therapy by prednisone and MTX was continued Fig. [1](#Fig1){ref-type="fig"}. Fig. 1Timeline of interventions and outcomes

Retrospectively, the joint fluid sampled on day 4 also tested positive for *L. bozemanii* by 23S--5S PCR. Five specimens (1 collected on day 4, and 4 on day 14) were plated onto BCYE, BMPA and MWY plates (Oxoid, Dardilly, France). Only 1 day-14 sample grew *L. bozemanii* after 9 days. A *L. bozemanii* seroconversion (\< 1/16 before admission, 1/256 on day 53) was demonstrated by in-house serology.

Regarding the source of infection, no clinical or radiological pneumonia was diagnosed before or during the course of the infection. *L. bozemanii* inoculation from asphalt at the time of her fall was strongly suspected. We hypothesized that the immunosuppressive treatment contributed to development of the infection and delayed diagnosis.

Discussion and conclusions {#Sec3}
==========================

When examining this case alongside those previously published and summarized in Table [1](#Tab1){ref-type="table"} (*n* = 9) \[[@CR3]--[@CR11]\], it is of note that *Legionella* arthritis was mostly identified incidentally by 16S rRNA PCR, which is consistent with the characteristics of the bacterium that does not usually grow on standard media. Interestingly, 2 clinical presentations can be distinguished. The first is monoarthritis (*n* = 7) that were all due to non-Lp1 strains and mainly reported in immunosuppressed patients (*n* = 6) with no history of pneumonia (*n* = 7); in 5 of the 7 cases, skin trauma close to the affected joint (*n* = 2) or an intra-articular injection or joint surgery (*n* = 3) was reported before arthritis. In contrast, cases of polyarthritis (*n* = 3) were all due to Lp1 and observed in patients with no immunosuppressive treatment who presented pneumonia at the time or before the diagnosis of arthritis. This dichotomous epidemiology suggests different physiopathological pathways leading to joint infection, which may result from both strain- and patient-related factors. Table 1Demographic characteristics, clinical features, and microbiological diagnoses of the case reports of *Legionella* arthritis, including the current caseCaseGenderAge (y)LocalizationStrainMicrobiological diagnosisMedical historyImmunosuppressive treatmentSuspected origin of the infectionPneumoniaCurrent caseFemale56Left wrist*L. bozemanii*16S rRNA PCR, cultureAnti-synthetase syndromeOral and intra-articular CS, MTX, tocilizumabWound after fall on a wet asphaltNoBanderet et al. 2017 \[[@CR3]\]Female90Left wrist*L. cincinnatiensis*16S rRNA PCR, culturePresumed chondrocalcinosis, chronic kidney diseaseOral and intra- articular CSIntra-articular CS injectionNoJust et al. 2012 \[[@CR4]\]Female71Left knee*L. bozemanii*16S rRNA PCR, cultureDermatomyositisOral CS, MTXSkin biopsyNoFernández-Cruz et al. 2011 \[[@CR5]\]Female83Right knee*L. micdadei*16S rRNA PCR, cultureRheumatoid arthritisOral CS, MTXReplacement of prosthesis the year beforeNoFlendrie et al. 2011 \[[@CR6]\]Female58Right knee*L. dumoffii*16S rRNA PCR, cultureSystemic erythematosus lupus-like diseaseOral and intra-articular CS, MTXIntra-articular injection 2 days beforeNoDugar et al. 2009 \[[@CR7]\]Male56Left foot*L. longbeachae*CultureRheumatoid arthritis, diabetes mellitusOral CS, MTXUnknownNoLinscott et al. 2004 \[[@CR8]\]Female80Right MCP joint*L. pneumophila* serogroup 4Culture on chocolate agarNoNoUnknownNoThurneysen and Boggian 2014 \[[@CR9]\]Male70Right kneeLeft ankle*L. pneumophila* serogroup 116S rRNA PCR, cultureSecondary thymoma- associated immunoglobulin deficiencyNoUnknownYes, 5 months beforeNaito et al. 2007 \[[@CR10]\]Female80Left and Right ankle*L. pneumophila* serogroup 1Urinary antigen, 16S rRNA PCRChronic kidney diseaseNoUnknownYes, LD 16 days beforeBemer et al. 2002 \[[@CR11]\]Male51Right wrist and ankle, both knees*L. pneumophila* serogroup 1Urinary antigen, Culture on mycobacteria mediumRecurrence of thymoma 1 year beforeNoUnknownYes, at the same time*CS* Corticosteroid, *LD* Legionnaires' disease, *MCP* Metacarpophalangeal, *MTX* Methotrexate, *rRNA PCR* ribosomal ribonucleic acid polymerase chain reaction

While more than 70 *Legionella* species have been isolated from freshwater and soil environments, less than half have been observed in clinical settings, and Lp1 is responsible for the vast majority of LD cases worldwide \[[@CR1]\]. In contrast with pneumonia, non-Lp1 *Legionella* strains are predominant among the cases of monoarthritis reported in the literature (Table [1](#Tab1){ref-type="table"}). This particular epidemiology is consistent with the environmental distribution of *Legionella* strains \[[@CR12]\] and the direct mode of transmission from their natural niche; a similar epidemiology has been described for skin and soft tissue *Legionella* infections \[[@CR13]\].

Host response to *Legionella* infections involves both innate and adaptive immunity \[[@CR14], [@CR15]\] and immunosuppressive therapies such as systemic CS, cytotoxic chemotherapies, and biological therapies (i.e. tumor necrosis factor inhibitors) are risk factors for *Legionella* infections \[[@CR15]--[@CR17]\]. Post-inoculation arthritis were described in patients receiving CS with or without MTX (Table [1](#Tab1){ref-type="table"}), suggesting that inoculated *Legionella* was not cleared at the first step of infection. Three cases received intra-articular CS that constitutes both a gateway for environmental germs and an additional local risk factor for infection. In the case described herein, the patient also received tocilizumab, an IL-6 receptor antagonist. A case of Lp1 pneumonia in a patient under tocilizimab has been described \[[@CR18]\]. As described herein, the patient presented no fever as tocilizumab inhibits IL-6, an inflammation and fever mediator \[[@CR19]\], and, by delaying the diagnosis, tocilizumab contributes to uncontrolled infections.

Another clinical feature of *Legionella* arthritis is polyarthritis occurring during the course or after pneumonia. Interestingly, the reported cases are all due to Lp1 strains that predominate in LD (Table [1](#Tab1){ref-type="table"}) suggesting secondary joint infections after bacterial blood dissemination. Accordingly, cases of Lp1 bacteremia have been described \[[@CR20]--[@CR22]\], and Lindsay et al. reported that up to 80.5% of patients present an Lp1 blood positive PCR after LD onset \[[@CR23]\]. Nevertheless, non-Lp1 bacteremias have also been described \[[@CR24], [@CR25]\] and no data comparing blood bacterial loads between Lp1 and non-Lp1 strains are available.

In conclusion, the clinical presentation of *Legionella* arthritis reveals the mode of infection and orientates the microbiological diagnosis towards either Lp1 or non-Lp1. In both contexts, 16S rRNA and *Legionella* specific PCRs are key factors for the diagnosis.

CS

:   Corticosteroid

LD

:   Legionnaires' disease

Lp1

:   *Legionella pneumophila* serogroup 1

MCP
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MTX

:   Methotrexate

rRNA PCR

:   Ribosomal ribonucleic acid polymerase chain reaction
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